Content
All Posts > Content under Pharma/Biotech
S&P 500 May Eye Higher Levels On Upbeat Earnings, Stimulus Hopes
Article By:
DailyFX
Read
Sunday, October 18, 2020 10:31 AM EDT
The S&P 500 index retreated from a six-week high since the start of the earnings season, in which big American banks delivered strong Q3 results. More than 80% of the S&P 500 firms which have released results so far, have smashed analysts’ forecasts.
Who Rocks? The Economic Modern Family, That’s Who!
Article By:
Michele Schneider
Read
Sunday, October 18, 2020 4:38 AM EDT
In spite of no passing stimulus, mixed economic data, rising COVID cases and a wild pre election season, for the first time since we can remember, the Economic Family is brushing off most of the negativity.
Alkermes: Progress In Antipsychotics
Article By:
MoneyShow.com
Read
Saturday, October 17, 2020 6:16 PM EDT
Alkermes has the potential to generate solid sales based on its ability to alleviate serious mental illness while safety mitigating weight gain that is common in antipsychotics.
In this article: ALKS
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
Article By:
ChinaBio® Today
Read
Saturday, October 17, 2020 1:14 PM EDT
Curon Biopharma, a Shanghai clinical-stage in-licensing company, acquired China rights to Tenalisib, a dual PI3K delta and gamma inhibitor, from Rhizen Pharma. Rhizen will receive milestone payments worth up to $149.5 million, plus royalties.
Walgreens Boots Alliance (WBA) Beats Q4 Earnings And Revenue Estimates
Article By:
Zacks Investment Research
Read
Thursday, October 15, 2020 10:48 AM EDT
Walgreens Boots Alliance came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.43 per share a year ago.
In this article: WBA
Cannabis Central: Pure-Play Pot Stock Index Declined Again On Wednesday
Article By:
Lorimer Wilson
Read
Thursday, October 15, 2020 10:14 AM EDT
The Pure-Play Pot Stock Index went down Wednesday with 17 of the 25 constituents declining, 7 advancing and one with no change in price. 2 advanced by +5% and 3 declined by +5%. 2 of the 3 industry categories also went down.
Market Briefing For Thursday, Oct. 15
Article By:
Gene Inger
Read
Thursday, October 15, 2020 3:10 AM EDT
It is a more cautious time, based on pandemic, on politics, on expensive stock leadership, while the more-mundane stocks aren't particularly pricey at all. But of course that presumes we emerge from the bunker-lifestyle quickly enough.
Market Briefing For Wednesday, Oct.14
Article By:
Gene Inger
Read
Wednesday, October 14, 2020 1:56 AM EDT
Tuesday's S&P behavior was about as anticipated, choppy with a bit of late comeback, with nothing earthshaking as far as the market itself, while clearly the Nation for sure needs more sooner, to fight COVID. Both testing and treatment.
Cannabis Central: The Pure-Play Pot Stock Index Continued To Advance On Monday
Article By:
Lorimer Wilson
Read
Tuesday, October 13, 2020 8:57 AM EDT
Monday was the fourth consecutive day that the Pure-Play Pot Stock Index has gone up. 19 of the 25 constituents went up in price, one had No Change in price and 5 declined. Two of the three industry categories went up as well.
Johnson & Johnson COVID-19 Vaccine Trial Halted
Article By:
Admiral Markets
Read
Tuesday, October 13, 2020 3:40 AM EDT
Pharmaceutical and consumer products giant Johnson & Johnson announced it was temporarily halting its COVID-19 vaccine trial after a participant developed an unexplained illness.
In this article: JNJ
Market Briefing For Tuesday, Oct. 13
Article By:
Gene Inger
Read
Tuesday, October 13, 2020 3:12 AM EDT
Columbus Day Perspectives generally surround the market's continuation on the upside fairly dramatically led by the 'super-cap' usual suspects, which is considered a blow-off by some.
Columbus Day
Article By:
Vivian Lewis
Read
Monday, October 12, 2020 2:53 PM EDT
Despite banks being closed, US stock markets are in a frenzy (mostly bullish) over hopes for another stimulus package, and this has boosted shares of banks in a week when many big ones are reporting.